Premium
Inhibition of anti‐IgE induced skin response in normals by formoterol, a new β 2 adrenoceptor agonist, and terbutaline
Author(s) -
Gronneberg R.,
Zetterström O.
Publication year - 1990
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1990.tb00508.x
Subject(s) - terbutaline , formoterol , pharmacology , formoterol fumarate , immunoglobulin e , agonist , chemistry , histamine , bronchodilator , onset of action , medicine , endocrinology , budesonide , receptor , asthma , immunology , antibody
The intention of the present study was to compare formoterol and terbutaline regarding ability to inhibit immediate wheal and Hare responses (WFR) to antihuman IgE with focus on the duration of anti‐WFR action. Formoterol is a novel β 2 ‐adrenergic agonist with a prolonged duration of bronchodilation capacity after inhalation. The drugs injected intradermally 2 min prior to challenge with anti‐IgE in volunteers produced a dose‐dependent inhibition of the WFR in the range 1pg–100ng (formoterol) and Ing‐1μg (terbutaline). Formoterol was 70 times (flare) and 25 times (wheal) more potent (ID 40 ) than terbutaline on a weight basis. The duration of the anti‐WFR action for formoterol, injected in a 25 times lower dose than terbutaline, was significantly longer, namely > 24 h versus 8 h for terbutaline. The histanune induced wheal reaction was attenuated by 15% and 25% by terbutaline and formoterol, respectively. The results indicate a higher β 2 ‐receptor activity for formoterol with respect to inhibition of IgE‐dependent mast cell mediator release in addition to an anti‐leak effect exerted by both drugs. The prolonged duration of antagonistic effect by formoterol on the WFR to anti‐IgE might be due to the lipophilic property of the drug, with an expected higher retention of formoterol at the target tissue compared with the more hydrophilic compound terbutaline.